This text investigates the methodological framework required to evaluate the efficacy and clinical utility of screening programs for chronic diseases. Alan S. Morrison, an expert in epidemiological research, synthesizes complex statistical concepts to determine when screening procedures are indicated. The book provides a rigorous examination of how early intervention alters the natural history of disease, specifically addressing the impacts of lead time and prognostic selection on patient outcomes.

Experts and medical professionals frequently cite this work as a foundational text for understanding the statistical rigor required in screening evaluations. Readers often note the academic density of the prose, which serves as a comprehensive reference for researchers and public health practitioners.